Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 40

1.

Belatacept.

Vincenti F, Dritselis A, Kirkpatrick P.

Nat Rev Drug Discov. 2011 Aug 31;10(9):655-6. doi: 10.1038/nrd3536. No abstract available.

PMID:
21878974
2.

Belatacept in kidney transplantation.

Wojciechowski D, Vincenti F.

Curr Opin Organ Transplant. 2012 Dec;17(6):640-7. doi: 10.1097/MOT.0b013e32835a4c0d. Review.

PMID:
23044530
3.

Abatacept mechanism of action: concordance with its clinical profile.

Herrero-Beaumont G, Martínez Calatrava MJ, Castañeda S.

Reumatol Clin. 2012 Mar-Apr;8(2):78-83. doi: 10.1016/j.reuma.2011.08.002. Epub 2011 Nov 21. Review.

4.

Belatacept: a new era of immunosuppression?

El-Charabaty E, Geara AS, Ting C, El-Sayegh S, Azzi J.

Expert Rev Clin Immunol. 2012 Aug;8(6):527-36. Review.

PMID:
22992146
5.

Belatacept: in adult kidney transplant recipients.

Garnock-Jones KP.

BioDrugs. 2012 Dec 1;26(6):413-24. doi: 10.2165/11208900-000000000-00000. Review.

PMID:
22928660
6.

Abatacept: a novel therapy approved for the treatment of patients with rheumatoid arthritis.

Lundquist L.

Adv Ther. 2007 Mar-Apr;24(2):333-45. Review.

PMID:
17565924
7.

New immunosuppressive protocols with the advent of novel biological drugs.

Cruzado JM, Bestard O, Grinyó JM.

Transplantation. 2009 Aug 15;88(3 Suppl):S20-3. doi: 10.1097/TP.0b013e3181af666c. Review.

PMID:
19667957
8.

Profile of belatacept and its potential role in prevention of graft rejection following renal transplantation.

Gupta G, Womer KL.

Drug Des Devel Ther. 2010 Dec 1;4:375-82. doi: 10.2147/DDDT.S10432. Review.

9.

Biological agents in kidney transplantation: belatacept is entering the field.

Wéclawiak H, Kamar N, Ould-Mohamed A, Cardeau-Desangles I, Rostaing L.

Expert Opin Biol Ther. 2010 Oct;10(10):1501-8. doi: 10.1517/14712598.2010.514901. Review.

PMID:
20726688
10.

Challenges and opportunities in targeting the costimulation pathway in solid organ transplantation.

Wojciechowski D, Vincenti F.

Semin Immunol. 2011 Jun;23(3):157-64. doi: 10.1016/j.smim.2011.07.002. Epub 2011 Aug 19. Review.

PMID:
21856169
11.
12.

T-cell co-stimulatory blockade in transplantation: two steps forward one step back!

Riella LV, Sayegh MH.

Expert Opin Biol Ther. 2013 Nov;13(11):1557-68. doi: 10.1517/14712598.2013.845661. Epub 2013 Oct 1. Review.

PMID:
24083381
13.

Belatacept: a new biologic and its role in kidney transplantation.

Su VC, Harrison J, Rogers C, Ensom MH.

Ann Pharmacother. 2012 Jan;46(1):57-67. doi: 10.1345/aph.1Q537. Epub 2012 Jan 3. Review.

PMID:
22215686
14.

Advances in immunosuppression for kidney transplantation: new strategies for preserving kidney function and reducing cardiovascular risk.

Bestard O, Campistol JM, Morales JM, Sánchez-Fructuoso A, Cabello M, Cabello V, Pallardó LM, Grinyó JM.

Nefrologia. 2012 May 14;32(3):374-84. doi: 10.3265/Nefrologia.pre2012.Jan.11176. Epub 2012 Apr 17. Review. English, Spanish.

15.

Costimulation blockade in autoimmunity and transplantation.

Vincenti F.

J Allergy Clin Immunol. 2008 Feb;121(2):299-306; quiz 307-8. doi: 10.1016/j.jaci.2008.01.002. Review.

PMID:
18269922
16.

The complexities of T-cell co-stimulation: CD28 and beyond.

Sperling AI, Bluestone JA.

Immunol Rev. 1996 Oct;153:155-82. Review. No abstract available.

PMID:
9010723
17.

Co-stimulation blockade as a new strategy in kidney transplantation: benefits and limits.

Snanoudj R, Zuber J, Legendre C.

Drugs. 2010 Nov 12;70(16):2121-31. doi: 10.2165/11538140-000000000-00000. Review.

PMID:
20964456
18.

Belatacept for kidney transplant recipients.

Masson P, Henderson L, Chapman JR, Craig JC, Webster AC.

Cochrane Database Syst Rev. 2014 Nov 24;(11):CD010699. doi: 10.1002/14651858.CD010699.pub2. Review.

PMID:
25416857
19.

Belatacept: a novel biologic for maintenance immunosuppression after renal transplantation.

Martin ST, Tichy EM, Gabardi S.

Pharmacotherapy. 2011 Apr;31(4):394-407. doi: 10.1592/phco.31.4.394. Review.

PMID:
21449628
20.

Belatacept utilization recommendations: an expert position.

Grinyó JM, Budde K, Citterio F, Charpentier B.

Expert Opin Drug Saf. 2013 Jan;12(1):111-22. doi: 10.1517/14740338.2013.748747. Epub 2012 Dec 4. Review.

PMID:
23206310

Supplemental Content

Support Center